Sun Pharma's growth prospects look healthy; analysts positive on the stock

Majority of analysts positive on the stock; their average target price indicates an upside potential of 15 per cent

Premium

3 min read Last Updated : Jun 9 2023 | 9:44 PM IST

Listen to This Article

Sun Pharmaceutical Industries (Sun Pharma) reported a turnaround in the January-March quarter of the 2022-23 financial year (Q4FY23), declaring a profit after tax (PAT) of Rs 1,984 crore versus a

Topics : Sun Pharma pharmaceutical firms Q4 Results

First Published: Jun 9 2023 | 9:44 PM IST

Explore News

Stock Market Updates VinFast Auto | Tesla Stock To Watch Today Latest News Live Asian Games LIVE updates Vedanta Ltd.SSC CHSL Tier-1 Result 2023 Declared Gold-Silver Price Asian Games Day 4 Highlights Asian Games 2023 September 28 Schedule

Companies News

Adani group appoints new auditor for its main UK subsidiaries: Report Google, Facebook, X, Edtech Cos likely to pay up to 18% IGST from October 1

Sports News

Asian Games 2023: Indian men's 10m air pistol team strikes Gold at Asiad Asian Games LIVE updates, Day 5: Shooters win Gold; India medal tally - 22

India News

IPS officer who cracked Pulwama attack called back to Manipur amid violence Fire at Mukherjee Nagar: Delhi police books paying guest facility owner

Economy News

India's diamond firms in the rough as global trade sanctions mount Angel tax norms: Govt extends safe harbour to convertible preference shares

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Continue

Sun Pharma's growth prospects look healthy; analysts positive on the stock

Majority of analysts positive on the stock; their average target price indicates an upside potential of 15 per cent

Listen to This Article

Also Read

Sun Pharma Q3 net profit up 5.2% as sales grow in India, US markets

India business to boost pharma, after US sales prove to be a mixed bag

Sun Pharma Q4: Consolidated net profit at Rs 1,984 crore, revenue up 15%

From Adani Wilmar to Havells India: Q4 results to watch out for today

Mankind Pharma IPO to open next week: Check price band, GMP, other details

NTPC in a sweet spot; likely to be poised for leadership in renewables

FMCG stocks get a boost from improving prospects; analysts are bullish

Improving prospects drive auto major Maruti Suzuki India's shares

IT stocks witness fresh turbulence; posts biggest decline in nearly 2 mths

Heavyweights lift benchmarks; Sensex less than 1% away from all-time high

Explore News